P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA – A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE

por Slørdahl, T. S., Askeland, F. B., Hanssen, M. S. S., Sundt-Hansen, S. M., Vethe, N. T., Hjorth-Hansen, H., Fenstad, M. H., Waage, A., Hjertner, Ø., Schjesvold, F., Sundan, A.
Publicado 2022

Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial

por Gimsing, P, Hjertner, Ø, Abildgaard, N, Andersen, N F, Dahl, T G, Gregersen, H, Klausen, T W, Mellqvist, U-H, Linder, O, Lindås, R, Tøffner Clausen, N, Lenhoff, S
Publicado 2015